Researchers at the University of Illinois Urbana-Champaign have identified a promising compound, TC-2153, that significantly reduces the severity of epileptic...
A groundbreaking peptide, tentatively named A1R-CT, has demonstrated significant potential in augmenting the brain’s inherent defense mechanisms to prevent seizures...
A drug traditionally prescribed for rheumatoid arthritis has demonstrated a striking ability to quell brain-damaging seizures and reverse cognitive deficits...
Epilepsy, a complex neurological disorder affecting over 70 million individuals globally and approximately 3.4 million in the United States, is...
An international clinical trial, spearheaded by UCL (University College London) and Great Ormond Street Hospital (GOSH), has yielded highly encouraging...